Contrasting neuroendocrine responses in depression and chronic fatigue syndrome

[1]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[2]  Alexander J. Mitchell.  Glucocorticoids and the genesis of depressive illness , 1994, British Journal of Psychiatry.

[3]  T. Dinan.  Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model , 1994, British Journal of Psychiatry.

[4]  T. Silverstone,et al.  The prolactin response to d- and I-fenfluramine and to d-amphetamine in human subjects , 1993, International clinical psychopharmacology.

[5]  M. Farthing,et al.  Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d‐fenfluramine or placebo to healthy subjects , 1993, International clinical psychopharmacology.

[6]  T. Dinan,et al.  D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment. , 1992, Journal of affective disorders.

[7]  A. Komaroff,et al.  NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. , 1992, Annals of internal medicine.

[8]  T. Dinan,et al.  Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. , 1992, BMJ.

[9]  H. Vaudry,et al.  Glucocorticoids, Transmitters and Stress , 1992, British Journal of Psychiatry.

[10]  J. Turk.  The Fragile-X Syndrome , 1992, British Journal of Psychiatry.

[11]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[12]  T. Dinan,et al.  Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. , 1991, The American journal of psychiatry.

[13]  T. Dinan,et al.  d‐Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen‐induced alteration , 1991, Clinical endocrinology.

[14]  E. Ur.  6 Psychological aspects of hypothalamo—pituitary—adrenal activity , 1991 .

[15]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[16]  M. Sharpe,et al.  Mania and Recovery from Chronic Fatigue Syndrome , 1991, Journal of the Royal Society of Medicine.

[17]  E. Ur.  Psychological aspects of hypothalamo-pituitary-adrenal activity. , 1991, Bailliere's clinical endocrinology and metabolism.

[18]  J. Mann,et al.  Effects of age and gender on CNS serotonergic responsivity in normal adults , 1990, Biological Psychiatry.

[19]  James F. Jones,et al.  Chronic fatigue syndrome: a working case definition. , 1988, Annals of internal medicine.

[20]  R. Manna,et al.  Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects. , 1987, Hormone research.

[21]  E. D. de Kloet,et al.  Selective control by corticosterone of serotonin1 receptor capacity in raphe-hippocampal system. , 1986, Neuroendocrinology.

[22]  K. Siddle,et al.  New separation method for monoclonal immunoradiometric assays and its application to assays for thyrotropin and human choriogonadotropin. , 1984, Clinical chemistry.

[23]  Neville N. Osborne,et al.  Biology of serotonergic transmission , 1982 .

[24]  G. Fava,et al.  Life events and depression: A replication , 1981 .

[25]  D. N. Nandi,et al.  LIFE EVENTS AND DEPRESSION , 1981, Indian journal of psychiatry.

[26]  S. Checkley.  Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness , 1980, Psychological Medicine.

[27]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.